Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Block History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr

What is the latest Net Block ratio of MANKIND PHARMA ?

The latest Net Block ratio of MANKIND PHARMA is ₹18,620 Cr based on Mar2026 Consolidated results.
Year Net Block
Mar2026₹18,620 Cr
Mar2025₹19,004 Cr
Mar2024₹4,540 Cr
Mar2023₹4,245 Cr
Mar2022₹3,583 Cr

How is Net Block of MANKIND PHARMA Trending?

Years Net Block % Change
Mar2026 ₹18,620 Cr
-2.02
Mar2025 ₹19,004 Cr
318.61
Mar2024 ₹4,540 Cr
6.94
Mar2023 ₹4,245 Cr
18.49
Mar2022 ₹3,583 Cr -

Compare Net Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,365.1 Cr 2.1% 7.1% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.1%

7.1%

-0.6%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses